This protocol covers postmenopausal women presenting with genitourinary syndrome of menopause (GSM): genital dryness, burning, and irritation; diminished lubrication and pain during sexual activity (dyspareunia); and urinary symptoms including urgency, dysuria, and recurrent urinary tract infections.
Genitourinary syndrome of menopause encompasses the genital and lower urinary tract symptoms associated with postmenopausal estrogen deficiency. The symptomatic picture spans vaginal discomfort and dyspareunia through to urinary urgency, dysuria, and susceptibility to recurrent infections.
Relief of vulvovaginal symptoms including dryness and dyspareunia, improved sexual function, and relief of urinary symptoms.
Genitourinary syndrome of menopause (GSM) encompasses the genital and lower urinary tract symptoms associated with postmenopausal estrogen deficiency.
Symptoms may include genital dryness, burning and irritation; sexual symptoms of diminished lubrication and pain during sexual activity; and urinary symptoms of urgency, dysuria, and recurrent urinary tract infections.
Low-dose vaginal estrogen preparations are safe and effective treatments for vulvovaginal symptoms due to estrogen deficiency.
Low-dose vaginal estrogen improves sexual function in these women.
Low-dose vaginal estrogen therapy may provide benefit for urinary symptoms, including overactive bladder and urge incontinence, and may aid in prevention of recurrent urinary tract infections.
View source ↗